• Home
  • Photogallery
  • Stocks to buy: Sun Pharma, Kotak Mahindra Bank, Coforge among 5 shares for 29% return

Stocks to buy: Sun Pharma, Kotak Mahindra Bank, Coforge among 5 shares for 29% return

Stocks to buy: Brokerage firms have recommended five stocks having the potential to yield up to 29 per cent. One may consider the brokerage recommendations for positive yield.

(Disclaimer: The advice given here to invest in stocks is given by a brokerage house. These are not the views of Zee Business. Consult your advisor before investing.)

Written By: Sirali Gupta
Updated on: January 04, 2023, 10.32 AM IST
1/5

Coal India Brokerage firm Sharekhan has recommended buying shares of Coal India for a target price of Rs 280 apiece. On January 3, 2022, the stock ended at Rs 224. Investors can earn a return of Rs 56 per share or 25 per cent. Image source- Pixabay   

2/5

Kotak Mahindra Bank Brokerage firm Sharekhan has recommended buying shares of Kotak Mahindra Bank for a target price of Rs 2250 apiece. On January 3, 2022, the stock settled at Rs 1,835 per share. Investors can earn a return of Rs 415 per share or 23 per cent. Image source- Pixabay  

3/5

Coforge Brokerage firm Sharekhan has recommended buying shares of Coforge for a target price of Rs 4680 apiece. On January 3, 2022, the share of the IT company finished at Rs 4,008 apiece. Investors can earn a return of Rs 672 per share or 17 per cent. Image source- Pixabay

4/5

Sun Pharma Brokerage firm Sharekhan has recommended buying shares of Sun Pharma for a target price of Rs 1300 apiece. On January 3, 2022, the share of the pharmaceutical company closed at Rs 1,010 per share. Investors can earn a return of Rs 290 per share or 29 per cent. Image source- Pixabay  

5/5

Mahindra and Mahindra Brokerage firm Sharekhan has recommended buying shares of Mahindra and Mahindra for a target price of Rs 1550 apiece. On January 3, 2022, the stock of the automotive manufacturer ended at Rs 1,251. Investors can earn a return of Rs 299 per share or 24 per cent. Image source- Pixabay